Budapest Post

Cum Deo pro Patria et Libertate
Budapest, Europe and world news

Man wins $8bn court case over breast growth

A US jury finds Johnson & Johnson guilty of negligence over an anti-psychotic drug.

US drug firm Johnson & Johnson has been told to pay $8bn (£6.6bn) in punitive damages to a man over claims he was not warned that an anti-psychotic drug could lead to breast growth.

A Philadelphia jury made the award to Nicholas Murray, 26, whose case was one of thousands pending in the state.

His lawyers argued J&J's subsidiary Janssen put "profits over patients" in marketing the drug Risperdal.

J&J will appeal the ruling, which it said was "grossly disproportionate".

Professor Carl Tobias of the University of Richmond School of Law said he expected the large damages award to be lowered on appeal.

"A jury, if it's outrageous enough conduct, will award a big number and let the lawyers and judges work it out," he said.

However, Prof Tobias said the jury's verdict could mean the firm faces more large damages awards in other Risperdal cases.

"The kind of evidence in this trial may persuade another jury or judge to do something similar," he said.

The company is facing a series of complaints in the US for allegedly failing to properly warn of Risperdal's side effects.

The US giant is also facing court challenges over vaginal mesh implants and baby powder allegedly tainted with asbestos. Those cases are in addition to an ongoing legal battle over its role in the US opioid addiction crisis.

Johnson & Johnson reaches settlement with Ohio over opioid crisis

In numbers: the US opioid crisis

Johnson & Johnson shares drop after asbestos report

In August, Johnson & Johnson was ordered to pay $572m after a judge in Oklahoma ruled that the company contributed to an opioid epidemic in the state by running a "false and dangerous" sales campaign. The firm said it will appeal.

More recently, it agreed a $20.4m settlement with two counties in Ohio ahead of a trial about the opioid crisis, scheduled to take place later this month.

In the Risperdal lawsuit, Mr Murray said he developed breasts after his doctors prescribed the drug in 2003 when they diagnosed him with autism spectrum disorder.

Risperdal is approved for the treatment of schizophrenia and bipolar disorder, but doctors can legally prescribe medicine for any condition they see fit.

The company said it is confident the ruling will be overturned, and said the court prevented their legal team from presenting "key evidence" on the drug's labelling.

A jury in 2015 awarded Mr Murray $1.75m after finding the company was negligent in failing to warn consumers of the risks.

A state appeals court upheld the verdict in last year, but reduced it to $680,000.

AI Disclaimer: An advanced artificial intelligence (AI) system generated the content of this page on its own. This innovative technology conducts extensive research from a variety of reliable sources, performs rigorous fact-checking and verification, cleans up and balances biased or manipulated content, and presents a minimal factual summary that is just enough yet essential for you to function as an informed and educated citizen. Please keep in mind, however, that this system is an evolving technology, and as a result, the article may contain accidental inaccuracies or errors. We urge you to help us improve our site by reporting any inaccuracies you find using the "Contact Us" link at the bottom of this page. Your helpful feedback helps us improve our system and deliver more precise content. When you find an article of interest here, please look for the full and extensive coverage of this topic in traditional news sources, as they are written by professional journalists that we try to support, not replace. We appreciate your understanding and assistance.
Newsletter

Related Articles

0:00
0:00
Close
IMF Upgrades Global Growth Forecast as Weaker Dollar Supports Outlook
House Republicans Move to Defund OECD Over Global Tax Dispute
France Opens Criminal Investigation into X Over Algorithm Manipulation Allegations
Trump Steamrolls EU in Landmark Trade Win: US–EU Trade Deal Imposes 15% Tariff on European Imports
ChatGPT CEO Sam Altman says people share personal info with ChatGPT but don’t know chats can be used as court evidence in legal cases.
Intel Reports Revenue Beats but Sees 81% Rise in Losses
Politics is a good business: Barack Obama’s Reported Net Worth Growth, 1990–2025
UN's Top Court Declares Environmental Protection a Legal Obligation Under International Law
"Crazy Thing": OpenAI's Sam Altman Warns Of AI Voice Fraud Crisis In Banking
The Podcaster Who Accidentally Revealed He Earns Over $10 Million a Year
UK Government Considers Dropping Demand for Apple Encryption Backdoor
Japanese Man Discovers Family Connection Through DNA Testing After Decades of Separation
Russia Signals Openness to Ukraine Peace Talks Amid Escalating Drone Warfare
Switzerland Implements Ban on Mammography Screening
Pogacar Extends Dominance with Stage Fifteen Triumph at Tour de France
President Trump Diagnosed with Chronic Venous Insufficiency After Leg Swelling
CEO Resigns Amid Controversy Over Relationship with HR Executive
NVIDIA Achieves $4 Trillion Valuation Amid AI Demand
Tulsi Gabbard Unveils Evidence Alleging Political Manipulation of Intelligence During Trump Administration
Centrist Criticism of von der Leyen Resurfaces as she Survives EU Confidence Vote
Trump Announces Coca-Cola to Shift to Cane Sugar in U.S. Production
FIFA Pressured to Rethink World Cup Calendar Due to Climate Change
Zelensky Reshuffles Cabinet to Win Support at Home and in Washington
"Can You Hit Moscow?" Trump Asked Zelensky To Make Putin "Feel The Pain"
Church of England Removes 1991 Sexuality Guidelines from Clergy Selection
Superman Franchise Achieves Success with Latest Release
Hungary's Viktor Orban Rejects Agreements on Illegal Migration
Air India Pilot’s Mental Health Records Under Scrutiny
Jamie Dimon Warns Europe Is Losing Global Competitiveness and Flags Market Complacency
Moonshot AI Unveils Kimi K2: A New Open-Source AI Model
Martha Wells Says Humanity Still Far from True Artificial Intelligence
Nvidia Becomes World’s First Four‑Trillion‑Dollar Company Amid AI Boom
EU Delays Retaliatory Tariffs Amid New U.S. Threats on Imports
Trump Proposes Supplying Arms to Ukraine Through NATO Allies
US Opens First Rare Earth Mine in Over 70 Years in Wyoming
Bitcoin Reaches New Milestone of $116,000
Severe Heatwave Claims 2,300 Lives Across Europe
Declining Beer Consumption Signals Cultural Shift in Germany
Emails Leaked: How Passenger Luggage Became a Side Income for Airport Workers
Polish MEP: “Dear Leftists - China is laughing at you, Russia is laughing, India is laughing”
Western Europe Records Hottest June on Record
BRICS Expands Membership with Indonesia and Ten New Partner Countries
Elon Musk Founds a Party Following a Poll on X: "You Wanted It – You Got It!"
China’s Central Bank Consults European Peers on Low-Rate Strategies
France Requests Airlines to Cut Flights at Paris Airports Amid Planned Air Traffic Controller Strike
Poland Implements Border Checks Amid Growing Migration Tensions
Emirates Airline Expands Market Share with New $20 Million Campaign
Amazon Reaches Milestone with Deployment of One Millionth Robot
Yulia Putintseva Calls for Spectator Ejection at Wimbledon Over Safety Concerns
House Oversight Committee Subpoenas Former Jill Biden Aide Amid Investigation into Alleged Concealment of President Biden's Cognitive Health
×